| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035595514 |
| P356 | DOI | 10.1038/LEU.2015.44 |
| P698 | PubMed publication ID | 25697894 |
| P5875 | ResearchGate publication ID | 272518360 |
| P2093 | author name string | Y Yang | |
| Y Zhu | |||
| W Wang | |||
| B Lu | |||
| Y-J Zhang | |||
| T Wu | |||
| J-Z Cao | |||
| Y-X Li | |||
| Q-F Liu | |||
| S-Y Zhu | |||
| J-X Wu | |||
| Z-Y Yuan | |||
| F-Q Zhang | |||
| L-M Xu | |||
| L-T Qian | |||
| X-R Hou | |||
| P2860 | cites work | Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy | Q74836340 |
| Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type | Q81084420 | ||
| Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring | Q81736021 | ||
| Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma | Q82107025 | ||
| Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma | Q83797250 | ||
| Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma | Q83936477 | ||
| Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy | Q83979517 | ||
| A novel prognostic model for extranodal natural killer/T-cell lymphoma | Q84590199 | ||
| Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract | Q86562570 | ||
| A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 | ||
| Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type | Q28262300 | ||
| Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial | Q29393809 | ||
| Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project | Q33382121 | ||
| SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. | Q33402956 | ||
| Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy | Q34427305 | ||
| Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study | Q34479889 | ||
| Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. | Q35006668 | ||
| Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery | Q36135193 | ||
| How to build and interpret a nomogram for cancer prognosis | Q37103518 | ||
| The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods | Q38450591 | ||
| Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance | Q42284737 | ||
| Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents | Q43265366 | ||
| Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma | Q43666106 | ||
| Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma | Q44413889 | ||
| High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome | Q45221087 | ||
| Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy | Q45355975 | ||
| Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study | Q46462344 | ||
| Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group | Q46667240 | ||
| Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index | Q47671029 | ||
| Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type. | Q48393757 | ||
| Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. | Q50909161 | ||
| Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. | Q51316540 | ||
| New prognostic model for extranodal natural killer/T cell lymphoma, nasal type. | Q51323360 | ||
| Clinical features and prognostic model for extranasal NK/T-cell lymphoma. | Q53130963 | ||
| Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma. | Q53171649 | ||
| Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. | Q53231075 | ||
| Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia. | Q53233763 | ||
| Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease. | Q54785152 | ||
| Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial G | Q56784798 | ||
| A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer | Q59649675 | ||
| Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality | Q74619625 | ||
| P433 | issue | 7 | |
| P921 | main subject | extranodal NK/T-cell lymphoma, nasal type | Q4763254 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 1571-1577 | |
| P577 | publication date | 2015-02-20 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study | |
| P478 | volume | 29 |
| Q52886143 | A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined. |
| Q55222698 | A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection. |
| Q37746330 | A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy |
| Q55024723 | A nomogram for predicting survival in patients with breast cancer brain metastasis. |
| Q39999898 | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis |
| Q89748162 | A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group |
| Q45953902 | Association between coagulation function and patients with primary angle closure glaucoma: a 5-year retrospective case-control study. |
| Q54977575 | CD30 expression and survival in extranodal NK/T-cell lymphoma: a systematic review and meta-analysis. |
| Q88681039 | Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy |
| Q90012610 | Circulating tumor cells as a new predictive and prognostic factor in patients with small cell lung cancer |
| Q39746344 | Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience |
| Q49504358 | Current status and progress of lymphoma management in China |
| Q90510592 | Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) |
| Q64269086 | Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma |
| Q58806315 | Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy |
| Q97557982 | First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG |
| Q41476880 | Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram |
| Q91875938 | High C-Reactive Protein to Albumin Ratio Predicts Inferior Clinical Outcomes in Extranodal Natural Killer T-Cell Lymphoma |
| Q41694329 | Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer/T-cell lymphoma |
| Q41548046 | Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative |
| Q47548002 | Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas |
| Q89666740 | Prognostic Nomogram and Predictive Factors in Refractory or Relapsed Diffuse Large B-Cell Lymphoma Patients Failing Front-Line R-CHOP Regimens |
| Q92885779 | Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma |
| Q97423465 | Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type |
| Q48654812 | Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma |
| Q92267494 | Prognostic nomogram for adult patients with acute myeloid leukemia: A SEER database analysis |
| Q90087496 | Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study |
| Q37687651 | Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia |
| Q36949316 | Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy |
| Q40684954 | Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome |
| Q52606350 | Prognostic value of cancer antigen -125 for lung adenocarcinoma patients with brain metastasis: A random survival forest prognostic model. |
| Q99564958 | Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study |
| Q64081516 | Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma |
| Q58705127 | Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group |
| Q57790416 | Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) |
| Q90171240 | Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making |
| Q92675485 | What we should know about natural killer/T-cell lymphomas |
| Q89933345 | [Value of PET-CT clinical application in extranodal NK/T cell lymphoma] |
Search more.